Autologous cell therapy
Dec 23, 2019
Autologous cell therapy market: A new paradigm for kidney diseases
The past few decades have seen significant advancements in the medical sector. Technological intervention is one of them. Discovery of the remarkable property of Stem cells to be able to differentiate into different types of cell forms, replicate and express themselves as their parents is one of the milestone-disco...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
